Fact CheckerSign in

NCT07204535Recruiting

Post-TRaUmatic STress Disorder Induced by Gynecological Brachytherapy

Source: ClinicalTrials.gov · Last updated 4 Jun 2026

Brief summary (registry, in English)

This is a multicenter, prospective study aimed at providing information on the psychological effects (including post-traumatic stress symptoms) of utero-vaginal brachytherapy in patients with cervical cancer using self-administered questionnaires. The study also aims to assess the persistence of these symptoms over time, up to 5 years after brachytherapy. The results could help identify patients at risk of post-traumatic stress in this context and develop appropriate psychological interventions to improve their psychological well-being during and after treatment.

Status (registry)
Recruiting
Study type
Observational
Enrollment
80 (estimated)
First submitted
24 Sept 2025
Start date
17 Nov 2025
Primary completion date
17 Nov 2030
Lead sponsor
Centre Paul Strauss
NCT number
NCT07204535

What you commit to

  • Study type: Observational
  • Planned participants: 80
  • From 17 Nov 2025 to the primary completion date, 17 Nov 2030
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Inability to understand or respond to questionnaires due to a cognitive disorder, intellectual disability, language barrier, or psychiatric disorder that impairs judgment;

Other

  • Patient under juridic protection;
  • Pregnant or breastfeeding woman

Who the study is looking for

  • Confirmed diagnosis of cervical cancer with an indication for High-dose rate (HDR) or pulse-dose rate (PDR) uterovaginal brachytherapy;
  • Squamous cell carcinoma or other histological types;
  • WHO ≤ 2;
  • Ability to complete validated questionnaires in French;
  • Informed consent to participate in the study;
  • Patients over 18 years old

Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Groupement Hospitalier Sud - Hopital Lyon Sud
Coordinator of this site? Confirm its status
Pierre-BéniteFranceRecruiting
ICANS
Coordinator of this site? Confirm its status
StrasbourgFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.